ACDM 2025 was a dynamic convergence of innovation, expertise, and groundbreaking ideas that set the stage for the future of clinical trials. In an atmosphere fueled by curiosity and advancement, Clinion stood at the helm, driving conversations that matter and redefining what’s possible with AI in clinical trials.
Key Highlights from the Event
Agentic AI Unveiled – ACDM25 Exclusive First Look
At ACDM 2025, we introduced Agentic AI, a breakthrough in clinical trial intelligence. AI in clinical trials has traditionally been about automation, but Agentic AI takes it a step further by adapting and evolving to meet the needs of every trial in real-time with intelligent automation.
ACDM Award for Innovation
Clinion’s Clinical Data Science Team received the ACDM 2025 Award for Innovation in Clinical Data Management for its groundbreaking Clinical Data Review solution. This cutting-edge technology simplifies workflows with AI-driven data review, query automation, and real-time trial intelligence, empowering faster decision-making and greater efficiency, setting it apart from traditional solutions.
At ACDM 2025, Clinion’s AI solutions are taking center stage, ushering in a new era of intelligent, adaptive oversight for clinical trials. These groundbreaking innovations are moving beyond traditional automation, transforming clinical trial execution. Clinion is setting new benchmarks for efficiency and real-time decision-making, continuously redefining what’s possible with AI in clinical trials.
